1. Tumour innervation and neurosignalling in prostate cancer
   Brayden March et al, 2020, Nature Reviews Urology CrossRef
2. From Therapy Resistance to Targeted Therapies in Prostate Cancer
   Filipa Moreira-Silva et al, 2022, Frontiers in Oncology CrossRef
3. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes
   Marika Quadri et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
4. Increased Levels of Phosphorylated-P38α Induce WNT/β-Catenin and NGF/P75NTR/TrkA Pathways Disruption and SN56 Cell Death following Single and Repeated Chlorpyrifos Treatment
   Paula Moyano et al, 2024, Foods CrossRef
5. Drug-induced cell viability prediction from LINCS-L1000 through WRFEN-XGBoost algorithm
   Jiaxing Lu et al, 2021, BMC Bioinformatics CrossRef
6. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
   Leonardo Bernal et al, 2023, International Journal of Molecular Sciences CrossRef
7. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer
   N.E. Scholpa et al, 2016, Chemico-Biological Interactions CrossRef
8. NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism
   Maritza P. Garrido et al, 2022, International Journal of Molecular Sciences CrossRef
9. Overexpression of p75NTR in Human Seminoma: A New Biomarker?
   Anna Perri et al, 2021, Life CrossRef